Investors

Overview

Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.

Stock Quote

  

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

Recent News
Ra Pharmaceuticals Announces Selection for the First ALS Platform Trial by the Sean M. Healey & AMG Center for ALS at Mass General
Read More
Upcoming Events
More events are coming soon.

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridgepark Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061

info@rapharma.com